Published in J Bacteriol on January 01, 2001
Proteomics of protein secretion by Bacillus subtilis: separating the "secrets" of the secretome. Microbiol Mol Biol Rev (2004) 2.67
Global transcriptional response of Bacillus subtilis to heat shock. J Bacteriol (2001) 2.49
Autolysis of Lactococcus lactis is increased upon D-alanine depletion of peptidoglycan and lipoteichoic acids. J Bacteriol (2005) 1.49
A novel class of heat and secretion stress-responsive genes is controlled by the autoregulated CssRS two-component system of Bacillus subtilis. J Bacteriol (2002) 1.48
Role of HtrA in the virulence and competence of Streptococcus pneumoniae. Infect Immun (2004) 1.40
Role for serine protease HtrA (DegP) of Streptococcus pyogenes in the biogenesis of virulence factors SpeB and the hemolysin streptolysin S. Infect Immun (2004) 1.31
The Bacillus subtilis heat shock stimulon. Cell Stress Chaperones (2003) 1.26
Role for HtrA in stress induction and virulence potential in Listeria monocytogenes. Appl Environ Microbiol (2005) 1.24
Role of HtrA in surface protein expression and biofilm formation by Streptococcus mutans. Infect Immun (2005) 1.19
Comparative analysis of the roles of HtrA-like surface proteases in two virulent Staphylococcus aureus strains. Infect Immun (2005) 1.12
Stress-responsive systems set specific limits to the overproduction of membrane proteins in Bacillus subtilis. Appl Environ Microbiol (2009) 1.06
Towards the development of Bacillus subtilis as a cell factory for membrane proteins and protein complexes. Microb Cell Fact (2008) 1.05
High external pH enables more efficient secretion of alkaline α-amylase AmyK38 by Bacillus subtilis. Microb Cell Fact (2012) 0.85
Integrated OMICS guided engineering of biofuel butanol-tolerance in photosynthetic Synechocystis sp. PCC 6803. Biotechnol Biofuels (2013) 0.84
Molecular engineering of secretory machinery components for high-level secretion of proteins in Bacillus species. J Ind Microbiol Biotechnol (2014) 0.82
Signal perception by the secretion stress-responsive CssRS two-component system in Bacillus subtilis. J Bacteriol (2012) 0.79
Degradation of extracytoplasmic catalysts for protein folding in Bacillus subtilis. Appl Environ Microbiol (2013) 0.79
A novel two-component system involved in secretion stress response in Streptomyces lividans. PLoS One (2012) 0.79
Comparative proteomic analysis of high cell density cultivations with two recombinant Bacillus megaterium strains for the production of a heterologous dextransucrase. Proteome Sci (2006) 0.78
Contributions of the pre- and pro-regions of a Staphylococcus hyicus lipase to secretion of a heterologous protein by Bacillus subtilis. Appl Environ Microbiol (2009) 0.78
Analysis of the proteolysis of bioactive peptides using a peptidomics approach. Nat Protoc (2013) 0.78
Release of an HtrA-Like Protease from the Cell Surface of Thermophilic Brevibacillus sp. WF146 via Substrate-Induced Autoprocessing of the N-terminal Membrane Anchor. Front Microbiol (2017) 0.75
The Three Streptomyces lividans HtrA-Like Proteases Involved in the Secretion Stress Response Act in a Cooperative Manner. PLoS One (2016) 0.75
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene (1985) 213.67
The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47
Antibiotic-resistance cassettes for Bacillus subtilis. Gene (1995) 7.28
High-efficiency gene inactivation and replacement system for gram-positive bacteria. J Bacteriol (1993) 5.17
The activity of sigma E, an Escherichia coli heat-inducible sigma-factor, is modulated by expression of outer membrane proteins. Genes Dev (1993) 5.00
A temperature-dependent switch from chaperone to protease in a widely conserved heat shock protein. Cell (1999) 4.78
A two-component signal transduction system essential for growth of Bacillus subtilis: implications for anti-infective therapy. J Bacteriol (1998) 3.47
The HtrA family of serine proteases. Mol Microbiol (1997) 3.14
The Escherichia coli sigma(E)-dependent extracytoplasmic stress response is controlled by the regulated proteolysis of an anti-sigma factor. Genes Dev (1999) 2.44
Two distinct loci affecting conversion to mucoidy in Pseudomonas aeruginosa in cystic fibrosis encode homologs of the serine protease HtrA. J Bacteriol (1996) 2.13
Regulation of groE expression in Bacillus subtilis: the involvement of the sigma A-like promoter and the roles of the inverted repeat sequence (CIRCE). J Bacteriol (1995) 2.11
HtrA is the unique surface housekeeping protease in Lactococcus lactis and is required for natural protein processing. Mol Microbiol (2000) 2.09
Expression of ykdA, encoding a Bacillus subtilis homologue of HtrA, is heat shock inducible and negatively autoregulated. J Bacteriol (2000) 1.17
Principles of membrane protein assembly and structure. Prog Biophys Mol Biol (1996) 1.11
Influence of a cell-wall-associated protease on production of alpha-amylase by Bacillus subtilis. Appl Environ Microbiol (1998) 1.07
The influence of protein folding on late stages of the secretion of alpha-amylases from Bacillus subtilis. FEBS Lett (1998) 0.98
The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet (2002) 6.02
Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res (1997) 4.22
An in vitro method for assessing the plaque forming ability of oral bacteria. Arch Oral Biol (1967) 3.11
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO. J Med Genet (2004) 3.10
Base composition skews, replication orientation, and gene orientation in 12 prokaryote genomes. J Mol Evol (1998) 2.98
Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol (2006) 2.94
A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer (1984) 2.89
Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer. Br J Cancer (2004) 2.87
Familial breast cancer. BMJ (1994) 2.54
Uptake of screening and prevention in women at very high risk of breast cancer. Lancet (2001) 2.45
Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial. J Clin Oncol (1997) 2.39
Perception of risk in women with a family history of breast cancer. Br J Cancer (1993) 2.32
The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology (1995) 2.27
Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet (2003) 2.24
Codon usage and gene expression level in Dictyostelium discoideum: highly expressed genes do 'prefer' optimal codons. Nucleic Acids Res (1989) 1.91
High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy. Breast Cancer Res Treat (2001) 1.88
New family of regulators in the environmental signaling pathway which activates the general stress transcription factor sigma(B) of Bacillus subtilis. J Bacteriol (2001) 1.88
Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat (1999) 1.84
Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. Br J Cancer (1991) 1.83
Non-standard management of breast cancer increases with age in the UK: a population based cohort of women > or =65 years. Br J Cancer (2007) 1.80
Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J Clin Endocrinol Metab (1997) 1.79
The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer (1994) 1.75
Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases. Cancer (2001) 1.70
Treatment of advanced prostatic cancer with LHRH analogue ICI 118630: clinical response and hormonal mechanisms. Lancet (1983) 1.69
A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer. Eur J Cancer (1996) 1.67
The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer. Br J Cancer (1989) 1.65
Odontomyces viscosus, gen. nov., spec. nov., a filamentous microorganism isolated from periodontal plaque in hamsters. Sabouraudia (1965) 1.61
The prognostic significance of two epithelial membrane antigens expressed by human mammary carcinomas. Int J Cancer (1984) 1.61
Expression of AbrB, a transition state regulator from Bacillus subtilis, is growth phase dependent in a manner resembling that of Fis, the nucleoid binding protein from Escherichia coli. J Bacteriol (1997) 1.61
The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes (Lond) (2010) 1.61
Assessment of hormone dependence of comedo ductal carcinoma in situ of the breast. J Natl Cancer Inst (1997) 1.58
Cranberry products inhibit adherence of p-fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells. J Urol (2007) 1.57
Steroid-hormone receptors and survival after first relapse in breast cancer. Lancet (1984) 1.56
Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biol Neoplasia (1998) 1.52
A filamentous microorganism isolated from periodontal plaque in hamsters. 1. Isolation, morphology and general cultural characteristics. Sabouraudia (1963) 1.52
Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast. J Pathol (1996) 1.49
Can hair be used to screen for breast cancer? J Med Genet (2000) 1.49
Proteome composition and codon usage in spirochaetes: species-specific and DNA strand-specific mutational biases. Nucleic Acids Res (1999) 1.47
A radiation-controlled molecular switch for use in gene therapy of cancer. Gene Ther (2000) 1.45
Neuropathic joints. Semin Arthritis Rheum (1972) 1.44
Screening by mammography, women with a family history of breast cancer. Eur J Cancer (1998) 1.44
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. J Clin Oncol (1996) 1.44
Characterization of PBSX, a defective prophage of Bacillus subtilis. J Bacteriol (1990) 1.43
Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival. Cancer J Sci Am (2006) 1.43
Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer. Cancer Res (1994) 1.43
Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations. Clin Endocrinol (Oxf) (1994) 1.42
The relationship of body weight to response to endocrine therapy, steroid hormone receptors and survival of patients with advanced cancer of the breast. Br J Cancer (1988) 1.42
Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab (1999) 1.42
An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the Aromatase inhibitors letrozole and anastrozole. Eur J Cancer (2004) 1.39
Effect of clothing on dispersal of Staphylococcus aureus by males and females. Lancet (1974) 1.39
The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc Natl Acad Sci U S A (1989) 1.38
Relationship among oxidative stress, growth cycle, and sporulation in Bacillus subtilis. J Bacteriol (1987) 1.37
Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer (1993) 1.36
Controlled trial of adjuvant chemotherapy with melphalan for breast cancer. Lancet (1983) 1.35
A filamentous microorganism isolated from periodontal plaque in hamsters. II. Physiological and biochemical characteristics. Sabouraudia (1963) 1.34
Differential synthesis of spore coat proteins in prespore and prestalk cells of Dictyostelium. Proc Natl Acad Sci U S A (1982) 1.32
Characterisation of a repressor gene (xre) and a temperature-sensitive allele from the Bacillus subtilis prophage, PBSX. Gene (1990) 1.32
Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators. Psychooncology (1999) 1.32
Mechanism of action of adjuvant chemotherapy in early breast cancer. Lancet (1986) 1.30
Risk perception and cancer worry: an exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer. J Med Genet (2001) 1.28
Cancer experience in the relatives of an unselected series of breast cancer patients. Br J Cancer (1994) 1.28
Carcinomatous meningitis in solid tumours. Ann Oncol (1996) 1.27
Histological detection of oestrogen receptor in human breast carcinomas. Lancet (1980) 1.26
A comparison of three assays used for the in vitro chemosensitivity testing of human tumours. Br J Cancer (1984) 1.25
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial. J Clin Oncol (1990) 1.25
Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue. Endocr Relat Cancer (2006) 1.24
Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer. J Med Genet (2011) 1.23
Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma. BMJ (1988) 1.23
A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer. J Clin Oncol (1986) 1.22
Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnaires. Br J Cancer (1991) 1.21
Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int J Cancer (1991) 1.21
The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer (1988) 1.19
Oxidative stress and growth temperature in Bacillus subtilis. J Bacteriol (1987) 1.19
Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing. J Med Genet (2009) 1.18
Controlled trial of adjuvant chemotherapy with cyclophosphamide, methotrexate, and fluorouracil for breast cancer. Lancet (1984) 1.18
One of two osmC homologs in Bacillus subtilis is part of the sigmaB-dependent general stress regulon. J Bacteriol (1998) 1.18
Objective measurement of therapeutic response in breast cancer using tumour markers. Br J Cancer (1991) 1.18
The effects of drugs that cause neutropenia upon colony formation by bone marrow cells in semi-solid agar. Clin Sci Mol Med (1974) 1.17
Expression of ykdA, encoding a Bacillus subtilis homologue of HtrA, is heat shock inducible and negatively autoregulated. J Bacteriol (2000) 1.17
Carcinomatous meningitis in patients with breast cancer. An aggressive disease variant. Cancer (1994) 1.16
Leucocyte migration inhibition with aggregated gamma globulin in patients with rheumatoid arthritis. Clin Exp Immunol (1973) 1.16
Doxorubicin in advanced breast cancer: influence of schedule on response, survival and quality of life. Eur J Cancer (1992) 1.16
Changes in the extracellular matrix of the normal human breast during the menstrual cycle. Cell Tissue Res (1992) 1.14
Tumour markers in breast cancer. Br J Cancer (1979) 1.13
Tamoxifen for the prevention of breast cancer: psychosocial impact on women participating in two randomized controlled trials. J Clin Oncol (2001) 1.12
Allelic imbalance on chromosome 1 in human breast cancer. II. Microsatellite repeat analysis. Genes Chromosomes Cancer (1995) 1.12
Risk reducing mastectomy: outcomes in 10 European centres. J Med Genet (2008) 1.12
Expression of activated gelatinase in human invasive breast carcinoma. Clin Exp Metastasis (1993) 1.11
A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancer. Eur J Cancer (1995) 1.11
Serotypes of Cryptococcus neoformans in patients with AIDS. J Infect Dis (1986) 1.11
Effect of protein binding on levels of ampicillin and cloxacillin in synovial fluid. Clin Pharmacol Ther (1972) 1.11
Depression of bone marrow colony formation in gold-induced neutropenia. Br Med J (1975) 1.11
Molecular characterization of anterior-like cells in Dictyostelium discoideum. Dev Biol (1985) 1.10
Analysis of a ribose transport operon from Bacillus subtilis. Microbiology (1994) 1.10